Myriad Genetics

Snippet roundup: Fibrogen's Japanese hit and Madrigal's smash in Nash

Snippet roundup: J&J shrinks, while Vernalis vanishes altogether

November 03, 2017

GeneSight trial miss leaves Myriad depressed

January 09, 2017

A quiet year for mid-size medtech

December 20, 2016

Early visit from Santa puts the heat on Clovis

October 26, 2016

Lynparza shows that Parp competitors have it all to do

October 14, 2016

Snippet roundup: Biomarin boosted, Synairgen stung

October 12, 2016

Esmo event analyser – Tesaro tops the risers while Bristol-Myers is battered

October 09, 2016

Esmo – Tesaro enjoys a ta-dah moment

August 12, 2016

Snippet roundup: Lilly pill slips, Mek inhibitors reach limit, Myriad buys

August 24, 2015

Biomarin goes for pragmatism as the markets dip

Load More